Cataract surgery

Braille Institute Illuminates Low Vision Awareness Month with Workshops Led by Medical Experts

Retrieved on: 
Thursday, February 1, 2024
Online, Contact, Multimedia, Paratriathlon, LOS, Cataract surgery, Marketing, Lighting, Eye, Research, Cataract, FACS, Consultant, Cooking, UCLA, Love, CDC, Communication, Macular degeneration, Retina, Treatment, Braille Institute of America, Diabetic retinopathy, University, Medicine, Retail

LOS ANGELES, Feb. 1, 2024 /PRNewswire/ -- February is "Low Vision Awareness Month" and Braille Institute stands at the forefront, dedicated to shedding light on the challenges faced by individuals with low vision and offering invaluable resources. This month-long initiative includes free online workshops led by medical experts, delving into the latest advancements in the understanding, treatment, and prevention of various eye diseases.

Key Points: 
  • LOS ANGELES, Feb. 1, 2024 /PRNewswire/ -- February is "Low Vision Awareness Month" and Braille Institute stands at the forefront, dedicated to shedding light on the challenges faced by individuals with low vision and offering invaluable resources.
  • Braille Institute provides free low vision consultations on the use of magnification, lighting, and other devices to help individuals maximize their remaining vision.
  • Visit our website for low vision videos, information on various eye conditions, and to register for free low vision workshops.
  • Free Low Vision consultations are available in-person or remotely and conducted by certified and licensed Low Vision Specialists.

Alcon Showcases Cloud-based Planning and World-class Digital Technologies During AAO 2023

Retrieved on: 
Monday, October 30, 2023
Health, Surgery, Health Technology, Practice Management, Pharmaceutical, Optical, American Academy of Ophthalmology, Virtual reality, EEG microstates, NYSE, Eye, Phacoemulsification, Anatomical terms of location, Femtosecond, Cataract surgery, Equity, AAO, Bachelor of Science, Intraocular lens, Quality of life, Conference, Data, Participation, Instrument, Corniche (Abu Dhabi), Palace Hotel, American Academy, Surgeon, Ecosystem, Comparison, Quality, Zimmer Biomet Robotics, OCT, Patient, High, Lock (computer science), Physiology, Cataract, Nursing, Medical device, Ophthalmology, MD, IOL, LASIK, Alcon, Retina

Ophthalmologists, surgical staff, researchers, and industry leaders will have the opportunity to experience Alcon’s latest digital offerings and participate in additional Alcon events during the conference.

Key Points: 
  • Ophthalmologists, surgical staff, researchers, and industry leaders will have the opportunity to experience Alcon’s latest digital offerings and participate in additional Alcon events during the conference.
  • Alcon AAO event information and registration is available at MyAlconatAAO.com .
  • With the full, U.S. commercial availability of SMARTCataract, Alcon furthers its position as a leader in surgical ophthalmology.
  • For more information about the Alcon products and services on display at AAO, please visit MyAlconatAAO.com .

iTrack™ Advance Real-World Registry Data and CATALYST Study Data to be Presented at the 2023 ESCRS Annual Congress, Vienna

Retrieved on: 
Wednesday, September 6, 2023
Medical Devices, Health, Surgery, Clinical Trials, Optical, Biotechnology, Glaucoma, IOP, Cataract surgery, Surgeon, Registry, Cross-Cutting Programs Committee, FEBO, Cataract, Quality of life, MIGS, Congress, Patient, Collection, Hall, European Society of Gynaecological Oncology, EGS, Safety, Pharmaceutical industry, Dentistry, Birth control, Food delivery, Advance, MD

“This year’s official ESCRS scientific program will spotlight a number of papers and posters featuring our new iTrack™ Advance, including the interim 12-month results from the iTrack™ Global Data Registry.

Key Points: 
  • “This year’s official ESCRS scientific program will spotlight a number of papers and posters featuring our new iTrack™ Advance, including the interim 12-month results from the iTrack™ Global Data Registry.
  • The iTrack™ Global Data Registry is incorporated in the global International Glaucoma Surgery Registry (IGSR), an observational, non-interventional study of patients undergoing laser or surgical treatment for glaucoma.
  • Karl Mercieca, MD, FEBO will present the interim data update for the CATALYST Study at the 2023 ESCRS Annual Congress.
  • A summary of the ESCRS 2023 presentations and posters featuring iTrack™and the newly launched iTrack™ Advance is included below.

Bausch + Lomb Will Present New Scientific Data on its Surgical Products and Pipeline at European Society of Cataract and Refractive Surgery Annual Meeting

Retrieved on: 
Wednesday, September 6, 2023
Health, Surgery, General Health, Research, Science, Pharmaceutical, Optical, Cataract surgery, Surgeon, Very-small-aperture terminal, Refractive surgery, Aperture, Safety, Bausch, DRS, PRK, Bausch & Lomb, Toronto Congress Centre, Physician, CEST, Range, European Society for Primary Immunodeficiencies, Cataract, IOL, NYSE, Combination, MIMS, Telescope, Hospital, Dentistry, Silviculture, Medical device, Patient

Safety and performance results of the enVista® ENVY, an investigational premium IOL

Key Points: 
  • Safety and performance results of the enVista® ENVY, an investigational premium IOL
    Refractive outcomes of a low 0.90 diameter cylinder for the investigational enVista Toric IOL.
  • Bausch + Lomb will also host several educational and networking events during the meeting.
  • Other presentations featuring the company’s latest surgical technology will take place in the Bausch + Lomb booth, and Bausch + Lomb will host a Lift Off Celebration event to mark its 170th anniversary.
  • “Evaluation of Visual Outcomes in Patients with Complex Corneas Implanted with the IC-8 IOL.” J. Mehta et al.

SightMD Physicians Recognized by Newsweek's Best Ophthalmologists in American for 2023

Retrieved on: 
Friday, June 16, 2023
Cataract, Ophthalmology, Optometry, DO, Eyelid, MD, Patient, Cataract surgery, Nursing, LASIK, Newsweek

HAUPPAUGE, N.Y., June 16, 2023 /PRNewswire-PRWeb/ -- SightMD is excited to announce that its doctors have earned a few spots on Newsweek's prestigious list of America's Best Ophthalmologists 2023. Dr. Jeffrey Martin, Dr. James Gordon and Dr. John Mauro have all been included on this year's list. With the publication of Newsweek's America's Best Ophthalmologists 2023, our doctors were honored to rank among the 175 best professionals in their field, nationwide. This prestigious award is presented by Newsweek and Statista Inc., the world-leading statistics portal and industry ranking provider. The awards list was announced on June 14th, 2023 and can currently be viewed on the Newsweek website.

Key Points: 
  • SightMD is excited to announce that its doctors have earned a few spots on Newsweek's prestigious list of America's Best Ophthalmologists 2023.
  • HAUPPAUGE, N.Y., June 16, 2023 /PRNewswire-PRWeb/ -- SightMD is excited to announce that its doctors have earned a few spots on Newsweek's prestigious list of America's Best Ophthalmologists 2023.
  • With the publication of Newsweek's America's Best Ophthalmologists 2023, our doctors were honored to rank among the 175 best professionals in their field, nationwide.
  • The recommendations and quality score were analyzed to determine the 2022 list of "America's Best Ophthalmologists."

Alcon Announces Largest-Ever Scientific Presence at ASCRS 2023 and Expands Image-Guided Connectivity

Retrieved on: 
Monday, May 1, 2023
Research, Pharmaceutical, Optical, Medical Devices, Clinical Trials, Science, Surgery, Biotechnology, Medical Supplies, Other Science, Health, Diabetes, Ophthalmology, ASCRS, Zimmer Biomet Robotics, Patient, OCT, Randomized controlled trial, News, NYSE, Glaucoma, Trifocal lenses, Capsulorhexis, Electronic, Intraocular pressure, EEG microstates, Cataract, Cataract surgery, Refractive surgery, SENTRY, American Society of Cataract and Refractive Surgery, Phacoemulsification, Intraocular lens, Micheletti, IOP, Surgeon, ABO, Vision system, Refraction, Trial of the century, Annual general meeting, IOL, Society, Veterinary medicine, Telescopic sight, Medical device, Dentistry, Alcon, MD

Alcon ASCRS event information and registration is available at MyAlconatASCRS.com .

Key Points: 
  • Alcon ASCRS event information and registration is available at MyAlconatASCRS.com .
  • “The pace of innovation happening across eye care is extraordinary, and as the industry leader, we are excited to be leading the charge at ASCRS 2023,” said Sergio Duplan, President, North America at Alcon.
  • evaluates a head-to-head comparison of distance and intermediate vision of Clareon monofocal IOL and TECNIS Eyhance* monofocal IOL.
  • For information on Alcon events and news at ASCRS, please visit MyAlconatASCRS.com .

Visiox Pharma Announces FDA Acceptance of New Drug Application for Glaucoma

Retrieved on: 
Thursday, December 8, 2022
Cataract surgery, Food, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, NDA, Patient, File, New Drug Application, Brimonidine, FDA, Glaucoma, Inflammation, PDUFA, Pharmaceutical industry

The FDA has assigned a Prescription Drug User Fee Act (PDUFA) target action date of August 4, 2023.

Key Points: 
  • The FDA has assigned a Prescription Drug User Fee Act (PDUFA) target action date of August 4, 2023.
  • "If approved, Visiox has the potential to bring the first once-daily brimonidine to market for the treatment of glaucoma to patients and eye care professionals."
  • Visiox plans to soon submit a second New Drug Application for SDN-037 to the U.S. FDA to address an unmet need for cataract surgery.
  • PDP-716, SDN-037, and TearActTMdelivery technology were licensed by Visiox from Sun Pharma Advanced Research Company Ltd. For more information, please visit Visiox Pharma or LinkedIn .

Ophthalmic Femtosecond Lasers Global Market Report 2022: Government Initiatives and Awareness Campaigns to Control Visual Impairment Drive Growth - ResearchAndMarkets.com

Retrieved on: 
Friday, December 2, 2022
Technology, Optical, Health, Hardware, Cataract surgery, Laser, Research, Refractive error, Value, Hospital, Strategic management, Use, Market share analysis, Acquisition, Economic development, Heidelberg University Eye Clinic, COVID-19, Business Growth Fund, Growth, Customer support, Retail, Application

The "Ophthalmic Femtosecond Lasers Market Research Report by Type, Product, Application, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Ophthalmic Femtosecond Lasers Market Research Report by Type, Product, Application, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.
  • The Global Ophthalmic Femtosecond Lasers Market is projected to grow with a significant CAGR in the forecast period.
  • Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the Global Ophthalmic Femtosecond Lasers Market.
  • Based on Product, the market was studied across Diode Lasers, Excimer lasers, and Femtosecond Lasers.

Kala Pharmaceuticals Announces Appointment of Marjan Farid, M.D., to its Board of Directors

Retrieved on: 
Tuesday, November 1, 2022
Biologically based mental illness, Marketing, Security (finance), Severe cognitive impairment, Nasdaq, Board of directors, Textbook, U.S. Securities and Exchange Commission, Health, Ophthalmology, University of California, San Francisco Fetal Treatment Center, American Society of Cataract and Refractive Surgery, GLOBE, Research, Industry, Board, Society, COVID-19, Physician, Program, Stargardt disease, University of California, San Diego Performance-Based Skills Assessment, UCI, University of California, Irvine, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Eye, Education, Pathology, Coronavirus, University, NASDAQ, Cataract surgery, Private Securities Litigation Reform Act, KALA, Cataract, Refraction, Patient, Food, Corneal transplantation, Retinitis pigmentosa, Pharmaceutical industry, Biology

ARLINGTON, Mass., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ: KALA) (Kala or the Company), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare diseases of the eye, today announced the appointment of Marjan Farid, M.D., to its Board of Directors.

Key Points: 
  • ARLINGTON, Mass., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ: KALA) (Kala or the Company), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare diseases of the eye, today announced the appointment of Marjan Farid, M.D., to its Board of Directors.
  • Marjan is an outstanding addition to our Board of Directors.
  • She performs limbal stem cell transplants as well as artificial corneal transplantation for the treatment of patients with severe ocular surface disease.
  • Kala is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare diseases of the eye.

Visiox Pharma Appoints Industry Veteran Cynthia Matossian, M.D., as Chief Medical Officer

Retrieved on: 
Thursday, October 13, 2022
LinkedIn, ASC, University college, New Drug Application, George Washington University School of Medicine & Health Sciences, Patient, Standard of care, TJM, Cataract surgery, Woman, Inflammation, Partnership, Technology, Medical director, Company, Founder, Eye, ACES, American College, Ownership, Cornea, Glaucoma, Leadership, Pharmaceutical industry

"Dr. Matossian is an experienced and enthusiastic eye care leader, dedicated to providing compassionate care and advancing innovation," said Ryan Bleeks, Chief Executive Officer.

Key Points: 
  • "Dr. Matossian is an experienced and enthusiastic eye care leader, dedicated to providing compassionate care and advancing innovation," said Ryan Bleeks, Chief Executive Officer.
  • As Chief Medical Officer, Dr. Matossian will play a critical role in developing the medical affairs strategy for the company's near-term commercial products, as well as helping to forge strategic partnership engagements and evaluating portfolio expansion.
  • "I could not be more thrilled to be joining Visiox Pharma and working with such a dynamic management team," commented Cynthia Matossian, M.D.
  • PDP-716, SDN-037 and TearActdelivery technology were licensed by Visiox from Sun Pharma Advanced Research Company Ltd. For more information, please visit Visiox Pharma or LinkedIn .